Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07809698 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CT-AI Breast Cancer Opportunistic Screening Health Examination Study

Name: CT-AI Breast Cancer Opportunistic Screening Health Examination Study — clinical trial record (NCT07809698)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorThe First Affiliated Hospital with Nanjing Medical University

Started2026-09-01

View on ClinicalTrials.gov ↗

The First Affiliated Hospital with Nanjing Medical University

275 trials monitored

See 6 trials at risk

Breast Cancer

5,180 trials monitored

See 256 trials at risk

This study evaluates the clinical utility of a locked chest CT artificial intelligence model for opportunistic breast cancer screening among women undergoing health examinations. The study includes a retrospective validation phase and a prospective single-arm implementation phase. AI analyzes existing non-contrast chest CT images without additional CT examinations. Clinical physicians make further evaluation decisions based on AI outputs, imaging findings, ultrasound results and clinical information.

Trial Details

NCT Number	NCT07809698
Lead Sponsor	The First Affiliated Hospital with Nanjing Medical University
Conditions	Breast Neoplasms
Enrollment	30,000 participants
Start Date	2026-09-01
Primary Completion	2028-03-31 (estimated)
Study Completion	2030-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-09-09